eureKARE is an investment company focused on financing and developing synthetic biology innovation across Europe. Driven by the belief that synthetic biology holds the key to many of the world’s most pressing health and environmental challenges, eureKARE’s experienced team is focused on harnessing Europe’s untapped leadership in the field to build the companies of the future. eureKARE is championing a new model of start-up creation and development to create a dynamic ecosystem of early and later stage ventures through its network of biotech studios. eureKARE’s studios act as a bridge between academia and industry, helping to catalyze innovations into companies with access to all the ingredients they need to grow, prosper, and bring benefits to society.
Company Details
- Founded
- -
- Address
- Paris, 75008, Fr
- Industry
- Investment Banking
- NAICS
-
Investment Banking and Securities Dealing
- Website
- https://eurekare.eu
- Keywords
- Pasig.
- HQ
- Paris
Eurekare - Investing In Synbio Innovation Questions
Eurekare - Investing In Synbio Innovation's website is https://eurekare.eu
Eurekare - Investing In Synbio Innovation's LinkedIn profile is https://fr.linkedin.com/company/eurekare
Eurekare - Investing In Synbio Innovation's industry is
Investment Banking
Eurekare - Investing In Synbio Innovation's top competitors are
The Funding Team,
A.l.p. (Anne Lauvergeon Partners),
Avril,
Nordic Innovators P/s,
E-Pango,
Cdc Croissance,
Eurekare Corp.,
Merieux Equity Partners,
Mouradian Foundation,
Eureking.
Eurekare - Investing In Synbio Innovation's categories are Investment Banking
Eurekare - Investing In Synbio Innovation's founding year is 2020
